lecture 9: menopause Flashcards

1
Q

What is the menopause?

A
  • The menopause is the final menstrual period
  • the average age of menopause is around 51-52 years (age range 48 - 55 years)
  • defined retrospectively after 12 months of absent periods
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is perimenopause?

A
  • climacteric, menopause transition
  • the period when ovarian function declines, cycles are irregular and menopausal symptoms appear
  • begins mid to late forties, ends one year after menopause
  • lasts for years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is post menopause?

A
  • is the whole of women’s life after menopause
  • no periods, no ovulation, hormones low, cannot conceive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is early menopause?

A
  • 40 - 45 years
  • 5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is premature ovarian insufficiency?

A
  • premature menopause
  • menopause prior to 40 years
  • 1%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In what ‘state’ does a woman spend a lot of her life?

A
  • postmenopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many women can expect to reach the menopause?

A
  • 95% of women
  • female life expectancy has increased while age of menopause has remained constant
  • around a third of our life is spent beyond the menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the aetiology of menopause?

A
  • loss of ovarian follicular activity at menopause
  • decline in quantity and quality in the years preceding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many eggs are in the ovary?

A
  • atresia (degeneration) of ovarian follicles (eggs) during the lifespan
  • foetus at 20 weeks’ gestation
    • each ovary contains about 5 million follicles
  • term
    • 1-2 million follicles
  • puberty
    • 300 000 - 400 000
  • 37 years
    • 100 000, then rapid loss
  • perimenopausal threshold
    • <1000 follicles?
  • also a decline in quality of the follicles
  • the follicles are not lost just through ovulation
  • the vast majority of follicles are lost through atresia and apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the age related decline in follicle numbers?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are factors regulating the age at natural menopause?

A
  • poorly understood
  • not influenced by race, age of menarche, parity, OCP
  • genetic factors – are important
  • cigarette smoking
  • menopause is 1 - 2 years earlier
  • surgical history
    • hysterectomy may reduce the age at menopause by around 3 - 4 years
    • may be due to impairment of the ovarian blood supply
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the aetiology of premature menopause (POI)?

A
  • idiopathic
    • karyotypically normal
    • spontaneous POI (1%)
  • iatrogenic
    • surgery/chemo/radiotherapy (8 - 19% of women under 40)
  • rare causes:
    • galactosaemia (excess milk products, galactose is stored in the ovaries and is toxic to oocytes)
  • auto-immune
    • auto-immune
  • genetic
    • turner’s syndrome
    • fragile x syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What chromosomal abnormalities can affect ovarian function?

A
  • deletion in X chromosome between positions 13 and 26 can affect ovarian function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are physiologic changes associated with reproduction?

A
  • hypothalamus becomes activated around puberty with pulsatile release of GnRH
  • causes release of LH and FSH in a pulsatile manner from the anterior pituitary
  • FSH affects the ovaries
    • binds to granulosa cells and grows follicles
    • follicles produce oestrogen
    • results in secondary sexual development (eventually menstruation)
  • LH binds to theca cells (stroma around the follicles)
    • results in androgen production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the ovarian follicle?

A
  • secondary oocyte
  • corona radiata
  • cumulus oophorus
  • antrum
  • granulosa cells
  • theca interna
  • theca externa

produce oestrogen, activin, inhibin, follistatin, AMH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are varying stages of follicular development?

A
  • in the cortex
  • primary follicles as they are stimulated by FSH get larger, secondary
  • produce oestrogen which thickens the lining of the uterus, and increasing oestrogen causes a surge of LH → stimulates ovulation
17
Q

What are the phases of menstruation?

A
  • proliferative/follicular and secretory
  • follicular phase
    • FSH grows follicles
    • follicles grow the lining of the uterus
    • the glands are being developed
    • increased growth and height
    • as the follicles get larger and larger more oestrogen is produced
    • this results in an LH surge
    • produces a dominant follicle
    • this dominant follicle produces progesterone
    • important event because it stabilises this lining
  • secretory phase
    • further development of the glands
    • they become secretory
    • progesterone maintains the lining
  • women who are anovulatory and don’t produce progesterone
    • lining keeps growing and growing
    • very long and irregular cycles
    • at risk of endometrial hyperplasia and cancer
18
Q

Why is the dominant follicle able to continue growing for a while?

A
  • follicles as well as producing oestrogen produce inhibin
  • inhibin inhibits FSH
  • FSH peak but then starts to come down
  • yet one of the follicles continues to grow (dominant follicle) while the rest start to undergo atresia
  • the dominant follicle essentially self-selects
  • has more FSH receptors so can mop up more
19
Q

What is seen at the menopause?

A
  • ovarian primoridal follicle stores are exhausted by atresia and ovulation
  • ovulation will not occur after menopause, by this is retrospective
  • therefore use contraception until no periods for one year, as ovulation may occur right up until last period, though less frequently
20
Q

What is the aetiology of perimenopause?

A
  • ovarian primordial follicles decrease with age with an accelerated rate of loss from 37 years
  • follicles become progressively more resistant to stimulation by gonadotrophins
  • follicles that do develop may not secrete sufficient oestradiol (E2) and progesterone (P4) to produce regular menstruation
  • during perimenopause, irregular anovulatory cycles lead to prolonged unopposed E2
    • may lead to endometrial hyperplasia and cancer risk
21
Q

What are perimenopausal hormonal changes?

A
  • decreased ovarian inhibin B, AMH from the ovarian granulosa cells
  • gradual rise in FSH
  • fluctuations in oestradiol and progesterone
  • no substantial changes in androgen levels
  • sex steroid levels fluctuate markedly on a daily basis
  • measuring sex steroids is not useful when a woman of normal menopausal age develops symptoms
22
Q

What are hormone changes after the menopause?

A
  • oestradiol declines following menopause
  • FSH > 40 u/l
  • LH > 30-40 u/l
  • FSH starts to change before LH does
  • androstenedione is still produced by the ovary and adrenal gland and is converted in peripheral tissues to oestrone (E1)
  • androgens gradually decline during reproductive life but no dramatic change after menopause
23
Q

What are hormonal transitions?

A
  • FSH less than 10 is normal for younger
24
Q

What are the investigations and treatment in POI?

A
  • no periods for 4 months before age 40
  • FSH levels greater than 40mlU/nl on 2 occasions at least 1 month apart (never rely on one of level); day 2- 6 if cycling
  • exclusion of all other causes of absent periods, chromosome test
  • acutally still need contraception: lifetime chance of ever conceiving 5 - 10%
  • HRT/Contraception until around 50 years
  • important to test for fertility reasons, depression, the effect on bones and even cardiovascular risk
  • mortality increases by about 2% per year for the years of ‘periods lost’
25
Q

What are the consequences of menopause?

A
  • 20 - 40% of women have menopausal symptoms requiring treatment
  • short-term:
    • vasomotor symptoms (hot flushes, night sweats, formication)
    • urogenital symptoms: vaginal dryness, atrophic vaginitis, dyspareunia, dysuria, frequency of urine
    • sleep disturbance
    • reduced libido
    • depression, anxiety, labile mood
    • memory loss, fatigue (may be due to other not sleeping etc)
  • medium to long-term:
    • bone loss and osteoporosis
26
Q

What are hot flushes?

A
  • occur in ~80% of women
  • mechanisms not known
    • maybe due to abnormal hyperthalamic regulation, thermoregulation
  • last 4 min on average
  • can last up to hours
  • up to 30-50% resolve in 3/12 months
  • up to 40% may continue to have significant symptoms up to 10 years after menopause
  • increased with smoking, ETOH, surgical menopause, caffeine
  • main reason why women request treatment
  • oestrogen: most effective, 80% reduction
  • meditation, relaxation, CBT to reduce anxiety
  • think it is because of abnormal hype
27
Q

What are urogenital symptoms?

A
  • affects ~40% of postmenopausal women
  • persist or worsen over time
  • vaginal dryness
  • discomfort
  • dyspareunia
  • UTI
  • urgency
  • pallor dryness
  • redness
  • decreased rugosity
  • endometrial atrophy
  • first line is intravaginal oestrogen (not systemic)
28
Q

What affects emotional health during menopause?

A
  • empty nest
  • changing roles
  • frail or ill parents
  • loss of parents
  • loss of fertility, identity as a woman
  • sensual difficulties → marital difficulties
  • loss of partner
  • change in physical image/attractiveness
  • retirement of self or husband
  • adolescent children
29
Q

What are bone symptoms and osteoporosis?

A
  • oestrogen deficiency increases bone reabsorption
  • directly impairs gut calcium absorption
  • directly increases renal calcium excretion
  • sharp acceleration of bone loss during the initial 5 years following menopause (3 - 5%/year)
  • rate of loss then falls back to the age related loss of 1%/year
  • low bone mass increases fracture risk
  • prevalence 4% around 50 - 59 yo, greater than 50% by 80 yo
  • mortality is increased by 25% in the first year after a fracture
  • 25% of women, if they survive, need long term care
  • can be treated/prevented/managed by increasing weight bearing exercise, vitamin D, calcium intake (1200mg/day)
30
Q

What is the cardiovascular risk?

A
  • after menopause, increasing central adiposity, decreased resting energy expenditure, worsening CVS, lipid and metabolic profiles
  • hypertension (HT)
  • potentially mediated by low oestrogens and loss of inhibition of metabolic neuropeptides
  • HRT does not prevent Cardiovascular Disease (CVD)
31
Q

What is the risk of HRT?

A
  • combined oestrogen and progestogen, 50-79 years
  • increased risk of stroke (0.8/1000/year)
  • increased risk of clots (0.8/1000/year)
  • increased risk of breast cancer with greater than 5 years use (0.8/1000/year)
  • increased incidence of coronary heart disease
  • WHI JAMA 2002, 2004
32
Q

What are the benefits of HRT?

A
  • most effective treatment for menopausal symptoms
    • reduces frequency and severity of vasomotor symptoms by 75 - 85%
  • improves vaginal dryness
  • maintains or improves bone density and reduces fracture risk (1/1000 women/year)
  • may improve quality of life, sleep, muscle aches and pains
  • reduced colorectal cancer risk 0.8/1000/year (combined long term)
  • however because of the risks of HRT it is not the firstline treatment for osteoporosis
33
Q

What is HRT?

A
  • hormone replacement therapy
  • HRT contains oestrogen to treat symptoms and progestogen (if needed) to protect the endometrium
  • would generally never prescribe to someone over 60 years of age
  • usually prescribed for short-term gain
    • lowest dose possible
    • less than 5 years
    • individualised risk
  • contraindications
    • history of breast cancer
      • individualised
    • endometrial cancer
    • known clots and CVD
  • do use it in the short term to treat menopausal symptoms
    • mainly flushes, if required
  • if someone has a uterus and is given oestrogen alone they are at risk of endometrial cancer, so also give progestagen
  • can be administered in various ways:
    • pills
    • implant under the skin (under anterior abdominal skin)
    • patches (replaced every three days)
    • vaginal oestrogen
    • oestrogen gels
    • can be administered cyclically or continuously
    • cyclically:
      • oestrogen every day
      • progestagen two weeks on two weeks off
    • whenever you give a hormone and withdraw it, that will induce a period
34
Q

What are clinical practice guidelines for HRT?

A
  • ACEC, FDA
  • limited efficacy/safety data on complementary medicines
  • HRT indicated only for moderate to severe menopausal symptoms (flushes, urogenital), women should consider the risks and benefits
  • use HRT at the lowest dose and for the shortest duration possible, in perimenopausal or early postmenopausal women not older than 60 years
  • healthy women with no contraindications
  • do not use HRT for the prevention of CVD or dementia
  • HRT is not a first line treatment for osteoporosis
35
Q

What are conclusions about menopause?

A
  • menopause may be associated with significant physiological, physical emotional changes in mid-life
  • important to understand these changes so we may best address the needs of women
  • lifestyle evaluation and advice remain the cornerstone of advice for the mid-life woman